A new clinical rating scale for work absence and productivity: validation in patients with major depressive disorder
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The prevalence of major depressive disorder (MDD) is highest in working age people and depression causes significant impairment in occupational functioning. Work productivity and work absence should be incorporated into clinical assessments but currently available scales may not be optimized for clinical use. This study seeks to validate the Lam Employment Absence and Productivity Scale (LEAPS), a 10-item self-report questionnaire that takes 3-5 minutes to complete. METHODS: The study sample consisted of consecutive patients attending a Mood Disorders outpatient clinic who were in full- or part-time paid work. All patients met DSM-IV criteria for MDD and completed during their intake assessment the LEAPS, the self-rated version of the Quick Inventory for Depressive Symptomatology (QIDS-SR), the Sheehan Disability Scale (SDS) and the Health and Work Performance Questionnaire (HPQ). Standard psychometric analyses for validation were conducted. RESULTS: A total of 234 patients with MDD completed the assessments. The LEAPS displayed excellent internal consistency as assessed by Cronbach's alpha of 0.89. External validity was assessed by comparing the LEAPS to the other clinical and work functioning scales. The LEAPS total score was significantly correlated with the SDS work disability score (r = 0.63, p < 0.01) and the Global Work Performance rating from the HPQ (r = -0.79, p < 0.01). The LEAPS total score also increased with greater depression severity. CONCLUSION: The LEAPS displays good internal and external validity in a population of patients with MDD attending an outpatient clinic, which suggests that it may be a clinically useful tool to assess and monitor work functioning and productivity in depressed patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879 · cited 1×
“The concept of measurement-based care for depression [24], in which outcomes are assessed using validated scales and which is increasingly recommended by clinical guidelines for the management of MDD [25], should encompass work functioning as well as symptom severity.”
MethodRush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J. C., Ninan, P. T., Kornstein, S., Manber, R., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01866-8 · Cited by 3,829 · cited 1×
“Patients completed several questionnaires at initial assessment, including the Quick Inventory of Depressive Symptomatology, Self-Rated (QIDS-SR), a validated and widely used self-rated scale to assess severity and type of depressive symptoms [ 14 ].”
MethodCost of Lost Productive Work Time Among US Workers With Depression
Stewart, W. F. (2003) · JAMA · doi:10.1001/jama.289.23.3135 · Cited by 1,421 · cited 1×
“Almost half of people with chronic depression reported reduced productivity at work [9] and the costs of productivity losses associated with MDD have been estimated in the United States (in 2002) at over US$31 billion [10].”
BackgroundThe Economic Burden of Depression in the United States: How Did It Change Between 1990 and 2000?
Greenberg, P. E., Kessler, R. C., Birnbaum, H. G., Leong, S. A., Lowe, S. W., Berglund, P. A., & Corey-Lisle, P. K. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n1211 · Cited by 1,280
Assessing Psychiatric Impairment in Primary Care with the Sheehan Disability Scale
Leon, A. C., Olfson, M., Portera, L., Farber, L., & Sheehan, D. V. (1997) · The International Journal of Psychiatry in Medicine · doi:10.2190/t8em-c8yh-373n-1uwd · Cited by 987 · cited 1×
“In addition, subjects completed the Health and Work Performance Questionnaire (HPQ, [15]) and the Sheehan Disability Scale (SDS, [16]).”
MethodDescriptive Epidemiology of Major Depression in Canada
Patten, S. B., Wang, J. L., Williams, J. V., Currie, S., Beck, C. A., Maxwell, C. J., & el-Guebaly, N. (2006) · The Canadian Journal of Psychiatry · doi:10.1177/070674370605100204 · Cited by 443 · cited 1×
“The prevalence of MDD in the general population is highest in those of typical working age (15-64 years) [4] and, given the nature of the physical and cognitive symptoms Published: 3 December 2009”
BackgroundLam, R. W., Kennedy, S. H., Grigoriadis, S., McIntyre, R. S., Milev, R., Ramasubbu, R., Parikh, S. V., Patten, S. B., & Ravindran, A. V. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.041 · Cited by 431 · cited 1×
“The concept of measurement-based care for depression [24], in which outcomes are assessed using validated scales and which is increasingly recommended by clinical guidelines for the management of MDD [25], should encompass work functioning as well as symptom severity.”
MethodSelf-citationWang, P. S., Simon, G. E., Avorn, J., Azocar, F., Ludman, E. J., McCulloch, J., Petukhova, M. Z., & Kessler, R. C. (2007) · JAMA · doi:10.1001/jama.298.12.1401 · Cited by 408
The concept of recovery in major depression
FAVA, G. A., RUINI, C., & BELAISE, C. (2007) · Psychological Medicine · doi:10.1017/s0033291706008981 · Cited by 230 · cited 1×
“Clinical treatment studies in MDD now focus on symptom remission because of the evidence for poor outcomes predicted by the presence of residual depressive symptoms [22].”
BackgroundDruss, B. G., Schlesinger, M., & Allen, H. M. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.5.731 · Cited by 146
Cited by
Oluboka, O. J., Katzman, M. A., Habert, J., McIntosh, D., MacQueen, G. M., Milev, R. V., McIntyre, R. S., & Blier, P. (2018) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx081 · Cited by 104
Lam, R., Lamy, F.-X., Danchenko, N., Yarlas, A., White, M. K., Rive, B., & Saragoussi, D. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s175188 · Cited by 101
Self-citationLam, R. W., Parikh, S. V., Michalak, E. E., Dewa, C. S., & Kennedy, S. H. (2015) · Annals of Clinical Psychiatry · doi:10.1177/104012371502700209 · Cited by 62
Self-citationLam, R. W., Parikh, S. V., Ramasubbu, R., Michalak, E. E., Tam, E. M., Axler, A., Yatham, L. N., Kennedy, S. H., & Manjunath, C. V. (2013) · British Journal of Psychiatry · doi:10.1192/bjp.bp.112.125237 · Cited by 56
Self-citationLi, V. W., Sahota, J., Dev, D. K., Gill, D. D., Evans, V. C., Axler, A., Chakrabarty, T., Do, A., Keramatian, K., Nunez, J.-J., et al. (2024) · The Canadian Journal of Psychiatry · doi:10.1177/07067437241245331 · Cited by 8
Self-citation
Metadata
- Authors
- Lam, R. W., Michalak, E. E., & Yatham, L. N.
- Venue
- BMC Psychiatry
- Published
- 2009-12
- Volume
- 9
- Issue
- 1
- Pages
- 78-78
- ISSN
- 1471-244X (ISSN-L)
- OpenAlex
- W1967272156
- Cited by
- 88
- References
- 10
- FWCI
- 4.67
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A new clinical rating scale for work absence and productivity: validation in patients with major depressive disorder. https://app.cochat.ai/papers/10.1186/1471-244x-9-78
- The paper
- Lam, R. W., Michalak, E. E., & Yatham, L. N. (2009). A new clinical rating scale for work absence and productivity: validation in patients with major depressive disorder. BMC Psychiatry. https://doi.org/10.1186/1471-244x-9-78
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.